Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Guo

Showing results (601-610 of 631) with videos related to

Pageof 64
Sort By:
Radiology|August 2, 2016
Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines SurvivalLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
Journal of Cancer|April 21, 2018
Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort StudyLin-Quan Tang, Tong-Yu Lu, Yang Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy responseSai-Lan Liu, Xue-Song Sun, Jin-Jie Yan, et al.
Blood|January 11, 2015
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITPHai Zhou, Miao Xu, Ping Qin, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Cancer Letters|February 22, 2023
Retraction notice to "Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis" [Canc. Lett. 468 (2020) 27-40]Shan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
European Radiology|January 8, 2021
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control studyBei-Bei Xiao, Qiu-Yan Chen, Xue-Song Sun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
Cancer Research and Treatment|September 15, 2017
Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort StudyQiu-Yan Chen, Shao-Yan Guo, Lin-Quan Tang, et al.
Pageof 64

Showing results (601-610 of 631) with videos related to

Sort By:
Pageof 64
Radiology|August 2, 2016
Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines SurvivalLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
Journal of Cancer|April 21, 2018
Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort StudyLin-Quan Tang, Tong-Yu Lu, Yang Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy responseSai-Lan Liu, Xue-Song Sun, Jin-Jie Yan, et al.
Blood|January 11, 2015
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITPHai Zhou, Miao Xu, Ping Qin, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Cancer Letters|February 22, 2023
Retraction notice to "Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis" [Canc. Lett. 468 (2020) 27-40]Shan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
European Radiology|January 8, 2021
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control studyBei-Bei Xiao, Qiu-Yan Chen, Xue-Song Sun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
Cancer Research and Treatment|September 15, 2017
Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort StudyQiu-Yan Chen, Shao-Yan Guo, Lin-Quan Tang, et al.
Pageof 64